Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary - Contacts and Locations

Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary

This study is ongoing, but not recruiting participants.

Study NCT00066781. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00066781

Locations


United States, Iowa
	Mercy Cancer Center at Mercy Medical Center - North Iowa
	Mason City, Iowa, United States, 50401

United States, Minnesota
	Mayo Clinic Cancer Center
	Rochester, Minnesota, United States, 55905

United States, Nebraska
	Cancer Resource Center - Lincoln
	Lincoln, Nebraska, United States, 68510
	CCOP - Missouri Valley Cancer Consortium
	Omaha, Nebraska, United States, 68106

Sponsors and Collaborators

North Central Cancer Treatment Group

National Cancer Institute (NCI)

Investigators


Study Chair:	Matthew P. Goetz, MD	Mayo Clinic

Investigator:	Preston D. Steen, MD	Roger Maris Cancer Center at MeritCare Hospital

Investigator:	Charles Erlichman, MD	Mayo Clinic